Jump to:
loading...| Preferred Name |
Crizotinib |
|
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00026225 |
|
| Database_Cross_Reference |
VANDF:4030983 MTH:NOCODE NDFRT:N0000183253 MSH:C551994 NCI_FDA:53AH36668S NDDF:013917 NCI:C74061 SNOMEDCT_US:703638005 SNOMEDCT_US:703637000 MMSL:28080 ATC:L01XE16 RXNORM:1148495 MMSL:d07800 MEDCIN:343940 DRUGBANK:DB08865 MTHSPL:53AH36668S USPMG:MTHU002516 |
|
| label |
Crizotinib |
|
| MCID |
MC00810320 |
|
| PMOID |
PMO:00026225 |
|
| prefixIRI |
pmo:PMO_00026225 |
|
| prefLabel |
Crizotinib |
|
| Synonym |
Crizotinibum Crizotinib (substance) (R)-3-(1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-5-(1-(Piperidin-4-Yl)-1h-Pyrazol-4-Yl)Pyridin-2-Amine crizotinib (medication) crizotinib Crizotinib (product) CRIZOTINIB chemotherapeutics growth-signaling inhibitors crizotinib 2-Pyridinamine, 3-((1R)-1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-5-(1-(4-Piperidinyl)-1H-Pyrazol-4-yl)- (R)-Crizotinib |
|
| Tree Number |
T6.4.4.1.2.27.11 |
|
| subClassOf |
Create mapping